Irreversible inhibition of dipeptidyl peptidase 8 by dipeptide-derived diaryl phosphonates

被引:48
|
作者
Van der Veken, Pieter
Soroka, Anna
Brandt, Inger
Chen, Yuan-Shou
Maes, Marie-Berthe
Lambeir, Anne-Marie
Chen, Xin
Haemers, Achiel
Scharpe, Simon
Augustyns, Koen
De Meester, Ingrid
机构
[1] Univ Antwerp, Med Chem Lab, B-2610 Antwerp, Belgium
[2] Univ Antwerp, Med Biochem Lab, B-2610 Antwerp, Belgium
[3] Natl Hlth Res Inst, Div Biotechnol & Pharmaceut Res, Zhu Nan 350, Miaoli, Taiwan
关键词
D O I
10.1021/jm701005a
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Dipeptide-derived compounds, bearing various P2 residues and a diaryl pyrrolidin-2-yl phosphonate at the PI position, were evaluated as dipeptidyl peptidase 8 (DPP8) inhibitors. With these products, irreversible inhibition of DPP8 was observed. To obtain inhibitors with an improved activity and selectivity profile, a set of selected analogues containing a diaryl isoindolin-1-ylphosphonate at P1 was synthesized and evaluated. Within this latter series, compound 2e was shown to be a potent, irreversible inhibitor of DPP8, demonstrating very low affinity for DPP IV and DPP II.
引用
收藏
页码:5568 / 5570
页数:3
相关论文
共 36 条
  • [21] In vitro inhibition of dipeptidyl peptidase IV by peptides derived from the hydrolysis of amaranth (Amaranthus hypochondriacus L.) proteins
    Velarde-Salcedo, Aida J.
    Barrera-Pacheco, Alberto
    Lara-Gonzalez, Samuel
    Montero-Moran, Gabriela M.
    Diaz-Gois, Agustin
    Gonzalez de Mejia, Elvira
    Barba de la Rosa, Ana P.
    FOOD CHEMISTRY, 2013, 136 (02) : 758 - 764
  • [22] Dipeptidyl Peptidase Inhibition Enhances CD8 T Cell Recruitment and Activates Intrahepatic Inflammasome in a Murine Model of Hepatocellular Carcinoma
    Henderson, James M.
    Xiang, Michelle S. W.
    Huang, Jiali Carrie
    Wetzel, Stefanie
    Jiang, Linxuan
    Lai, Jack H.
    Wu, Wengen
    Kench, James G.
    Bachovchin, William W.
    Roediger, Ben
    McCaughan, Geoffrey W.
    Zhang, Hui Emma
    Gorrell, Mark D.
    CANCERS, 2021, 13 (21)
  • [23] Inhibition of DPP8/9 results in toxicity in preclinical species: Potential importance of selective dipeptidyl peptidase IV inhibition for the treatment of type 2 DM
    Lankas, G
    Leiting, B
    Roy, RS
    Eiermann, G
    Biftu, T
    Kim, D
    Ok, H
    Weber, A
    Thornberry, NA
    DIABETES, 2004, 53 : A2 - A2
  • [24] 2-[3-[2-[(2S)-2-cyano-1-pyrrolidinyl]-2-oxoethylamino]-3-methyl-1-oxobutyl]-1,2,3,4-tetrahydroisoquinoline:: A potent, selective, and orally bioavailable dipeptide-derived inhibitor of dipeptidyl peptidase IV
    Tsu, H
    Chen, X
    Chen, CT
    Lee, SJ
    Chang, CN
    Kao, KH
    Coumar, MS
    Yeh, YT
    Chien, CH
    Wang, HS
    Lin, KT
    Chang, YY
    Wu, SH
    Chen, YS
    Lu, IL
    Wu, SY
    Tsai, TY
    Chen, WC
    Hsieh, HP
    Chao, YS
    Jiaang, WT
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (01) : 373 - 380
  • [25] Multifunctional bioactive peptides derived from quinoa protein hydrolysates: Inhibition of α-glucosidase, dipeptidyl peptidase-IV and angiotensin I converting enzymes
    Mudgil, Priti
    Kilari, Bhanu Priya
    Kamal, Hina
    Olalere, Olusegun Abayomi
    FitzGerald, Richard J.
    Gan, Chee-Yuen
    Maqsood, Sajid
    JOURNAL OF CEREAL SCIENCE, 2020, 96
  • [26] (2S,4S)-1-[2-(1,1-Dimethyl-3-oxo-3-pyrrolidin-1-yl-propylamino)acetyl]-4-fluoro-pyrrolidine-2-carbonitrile: A potent, selective, and orally bioavailable dipeptide-derived inhibitor of dipeptidyl peptidase IV
    Yeh, Teng-Kuang
    Tsai, Ting-Yueh
    Hsu, Tsu
    Cheng, Jai-Hong
    Chen, Xin
    Song, Jen-Shin
    Shy, Horng-Shing
    Chiou, Mei-Chun
    Chien, Chia-Hui
    Tseng, Ya-Ju
    Huang, Chung-Yu
    Yeh, Kai-Chia
    Huang, Yu-Lin
    Huang, Chih-Hsiang
    Huang, Yu-Wen
    Wang, Min-Hsien
    Tang, Hung-Kuan
    Chao, Yu-Sheng
    Chen, Chiung-Tong
    Jiaang, Weir-Torn
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (12) : 3596 - 3600
  • [27] Vildagliptin-Derived Dipeptidyl Peptidase 9 (DPP9) Inhibitors: Identification of a DPP8/9-Specific Lead
    Benramdane, Siham
    De Loose, Joni
    Beyens, Olivier
    Van Rymenant, Yentl
    Vliegen, Gwendolyn
    Augustyns, Koen
    De Winter, Hans
    De Meester, Ingrid
    Van der Veken, Pieter
    CHEMMEDCHEM, 2022, 17 (15)
  • [28] Stromal cell-derived factor-1 is upregulated by dipeptidyl peptidase-4 inhibition and has protective roles in progressive diabetic nephropathy
    Takashima, Satoru
    Fujita, Hiroki
    Fujishima, Hiromi
    Shimizu, Tatsunori
    Sato, Takehiro
    Morii, Tsukasa
    Tsukiyama, Katsushi
    Narita, Takuma
    Takahashi, Takamune
    Drucker, Daniel J.
    Seino, Yutaka
    Yamada, Yuichiro
    KIDNEY INTERNATIONAL, 2016, 90 (04) : 783 - 796
  • [29] Dipeptidyl peptidase-4 inhibition improves cardiac function in experimental myocardial infarction: Role of stromal cell-derived factor-1α
    Connelly, Kim A.
    Advani, Andrew
    Zhang, Yanling
    Advani, Suzanne L.
    Kabir, Golam
    Abadeh, Armin
    Desjardins, Jean-Francois
    Mitchell, Melissa
    Thai, Kerri
    Gilbert, Richard E.
    JOURNAL OF DIABETES, 2016, 8 (01) : 63 - 75
  • [30] Selective inhibition of dipeptidyl peptidase I, not caspases, prevents the partial processing of procaspase-3 in CD3-activated human CD8+ T lymphocytes
    Bidère, N
    Briet, M
    Dürrbach, A
    Dumont, C
    Feldmann, J
    Charpentier, B
    de Saint-Basile, G
    Senik, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (35) : 32339 - 32347